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Abstract
Introduction: Glucose-6-phosphate dehydrogenase deficiency is an X-linked recessive disease
that causes acute or chronic hemolytic anemia and potentially leads to severe jaundice in response
to oxidative agents. This deficiency is the most common human innate error of metabolism,
affecting more than 400 million people worldwide.
Case presentation: Here, we present the first documented case of kernicterus in Panama, in a
glucose-6-phosphate dehydrogenase-deficient newborn clothed in naphthalene-impregnated
garments, resulting in reduced psychomotor development, neurosensory hypoacousia, absence of
speech and poor reflex of the pupil to light.
Conclusion: Mutational analysis revealed the glucose-6-phosphate dehydrogenase Mediterranean
polymorphic variant, which explained the development of kernicterus after exposition of
naphthalene. As the use of naphthalene in stored clothes is a common practice, glucose-6-
phosphate dehydrogenase testing in neonatal screening could prevent severe clinical consequences.
Introduction
Glucose-6-phosphate dehydrogenase (G6PD) is a house-
keeping enzyme that catalyzes the first step in the pentose
phosphate pathway, providing reducing power in the
form of nicotinamide adenosine dinucleotide phosphate
(NADPH). This metabolic pathway is the only source of
NADPH in erythrocytes and is therefore the mechanism
by which the cell damage caused by oxidative stress is
avoided [1,2].
Individuals deficient in G6PD are usually asymptomatic;
however, in some cases exposure to chemicals (for exam-
ple, naphthalene) and drugs (including sulfamides, anti-
pyretics, nitrofurane, primaquine and chloroquine) can
induce massive intravascular hemolysis. Among the clini-
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cal forms of this enzymatic deficiency are jaundice, acute
hemolytic anemia and chronic nonspherocytic hemolytic
anemia. A more severe consequence of neonatal hyperbi-
lirubinemia is kernicterus, a neurological syndrome
caused by the deposition of bilirubin in the brain tissues,
which results in severe consequences and even death [2-
4].
G6PD deficiency is an X-linked recessive disease and is the
most common human innate error of metabolism, affect-
ing more than 400 million people worldwide [5]. The
G6PD gene is highly polymorphic and more than 140
mutations have been described. In the Mediterranean,
Middle East, India, China and Southeast Asia, the distri-
bution of multiple alleles account for the total prevalence.
There are no reports concerning the prevalence of this
enzymatic deficiency in Panama; however, our prelimi-
nary studies indicate a high prevalence of G6PD defi-
ciency in this country (unpublished data).
Here we present a kernicterus case in a G6PD-deficient
newborn resulting in severe neurological damage.
Case presentation
Clinical history
A 4-day-old boy was admitted to the Hospital del Niño in
Panama. He was the first child of a healthy young woman
from a normal vaginal birth at term. He had an Apgar
score of 9 at 1 minute and 9 at 5 minutes, a birth weight
of 3.5 kg, body length of 53 cm and a 35 cm cephalic cir-
cumference. The newborn was hospitalized when clinical
examination revealed 4+ jaundice, hypoactivity, hypo-
rexia and generalized tonic-clonic seizures, requiring
management with anticonvulsives, phototherapy and
exchange transfusion. A history of use of naphthalene-
impregnated clothes was recorded. Analysis of clinical
symptoms and laboratory tests diagnosed the proband
with kernicterus by G6PD deficiency. Despite clinical
management, after 5 years the patient presented with
reduced psychomotor development, neurosensory hypoa-
cousia, absence of speech and poor reflex of the pupil to
light.
Laboratory data
Upon admission the patient presented total bilirubin val-
ues of 42.6 mg/dl (41.8 mg/dl from indirect bilirubin),
11.8 g/dl hemoglobin, 8% reticulocytes, O (Rh+) and B
(Rh+) blood types for child and mother, respectively, and
negative direct Coombs. G6PD testing was reported as
deficient, and the quantification of the serum levels of this
enzyme was 0.278 U/gHb (normal value range 4.6 to 13.5
U/gHb). Cranial magnetic resonance imaging demon-
strated hyperintense basal ganglia lesions on T2-weighted
images (Figure 1).
Mutational analysis
Determination of the G6PD polymorphic variant was
achieved by polymerase chain reaction and restriction
fragment length polymorphism (PCR-RFLP) as described
elsewhere [6]. Genomic DNA from the patient and one
heterozygote G6PD Mediterranean variant control were
obtained from heparinized peripheral blood with the salt-
ing out method described by Miller et al. [7]. We used 100
ng of DNA to amplify the region flanking nucleotide 563
containing the polymorphism. Amplified products were
then digested with the restriction enzyme Mbo II and the
digestion mix was electrophoresed in 10% polyacryla-
mide gel. Analysis showed the G6PD Mediterranean pol-
ymorphic variant genotype (Figure 2), which explained
the G6PD deficiency phenotype.
Conclusion
G6PD deficiency is an X-linked recessive disease and is the
most common human innate error of metabolism, affect-
ing more than 400 million people worldwide [5]. At the
Hospital del Niño of Panama, we have observed a high
prevalence of G6PD deficiency in our patients; however,
there are no reports concerning the prevalence of this
enzymatic deficiency in this country.
Here we presented the first documented case of ker-
nicterus in Panama in a G6PD-deficient newborn. The
Magnetic resonance imaging of the head Figure 1
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proband presented with hyperbilirubinemia (total
bilirubin of 42.6 mg/dl) and was treated with photother-
apy and two exchange transfusions. G6PD deficiency test-
ing was positive explaining the symptoms and clinical
signs. Mutational analysis demonstrated the G6PD Medi-
terranean polymorphic variant genotype (Figure 2).
The use of naphthalene-impregnated clothes prior to the
episodes of seizure explained the development of severe
jaundice that led to kernicterus. As the use of naphthalene
in stored clothes is a common practice, so testing for
G6PD as part of neonatal screening could prevent this
severe clinical consequence.
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Polymerase chain reaction and restriction fragment length  polymorphism determination Figure 2
Polymerase chain reaction and restriction fragment 
length polymorphism determination. The G6PD gene 
was amplified by polymerase chain reaction and digested with 
Mbo II. Lane 1, patient; lane 2, heterozygous control; lane 3, 
non-template control. M, 25 bp molecular marker.